Studies on the centrally mediated hypotensive activity of guanabenz
- 1 May 1976
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 37 (1), 31-44
- https://doi.org/10.1016/0014-2999(76)90005-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Central and peripheral contribution to the antihypertensive action of indoraminEuropean Journal of Pharmacology, 1975
- Inhibition of efferent sympathetic nerve activity by 5-hydroxytryptophan and centrally administered 5-hydroxytryptamineNeuropharmacology, 1975
- Possible mechanism of the hypotensive action of 2,6-dichlorobenzylidene aminoguanidine: Evidence for central noradrenaline receptor stimulationEuropean Journal of Pharmacology, 1973
- The central action of antihypertensive drugs, mediated via central α -receptorsJournal of Pharmacy and Pharmacology, 1973
- Reduction of sympathetic outflow by central administration of L-DOPA, dopamine and norepinephrineNeuropharmacology, 1973
- Effects of clonidine on aortic diameter and aortic baroreceptor activityEuropean Journal of Pharmacology, 1972
- New evidence for an α-adrenergic component in the sympathetic centres: Centrally mediated decrease in sympathetic tone by 1-dopa and its antagonism by piperoxane and yohimbineEuropean Journal of Pharmacology, 1972
- Inhibition of spontaneous sympathetic nerve activity by the antihypertensive agent Wy-8678Neuropharmacology, 1970
- 2,6-Dichlorobenzylidene amino guanidine acetate (Wy-8678). A new hypotensive agentCellular and Molecular Life Sciences, 1969
- Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 115)European Journal of Pharmacology, 1968